Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Regulatory News (FUTR)

Share Price Information for Future (FUTR)

Share Price is delayed by 15 minutes
Get Live Data
323.20    26.20 (8.82%)
Bid:
323.00
Ask:
324.40
Spread: 1.40 (0.433%)
Market Cap: £292.27m
FUTR Live PriceLast checked at - London Stock Exchange

Intraday Future Share Chart

Pre Stabilisation Notice

1 Jul 2025 11:21

RNS Number : 2309P
HSBC Bank plc
01 July 2025
 

1st July 2025

 

Future plc

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

Future plc

Guarantor (if any):

na

Aggregate nominal amount:

GBP 300,000,000

Description:

Fixed 5yr

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

3rd July 2025

Stabilisation period expected to end no later than:

8th August 2025

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAZZGGNGMGGKZM
Date   Source Headline
19th Apr 202211:00 amRNSNotice of Results
31st Mar 202211:03 amRNSTotal Voting Rights
24th Mar 20227:00 amRNSAcquisitions of WhatCulture.com & Waive
28th Feb 202210:28 amRNSTotal Voting Rights
17th Feb 20227:00 amRNSFurther re Rule 19.6(c) confirmation
11th Feb 202210:07 amRNSHolding(s) in Company
11th Feb 202210:06 amRNSDirector/PDMR Shareholding
8th Feb 20228:49 amRNSInvestor webinar
3rd Feb 20221:38 pmRNSDirector/PDMR Shareholding
3rd Feb 20221:36 pmRNSResult of AGM
3rd Feb 20227:00 amRNSTrading Update
31st Jan 20229:52 amRNSTotal Voting Rights
31st Jan 20229:51 amRNSHolding(s) in Company
25th Jan 202212:00 pmRNSInvestor webinar
17th Jan 20223:45 pmRNSHolding(s) in Company
4th Jan 202210:58 amRNSBlock listing Interim Review
4th Jan 202210:54 amRNSTotal Voting Rights
17th Dec 202111:52 amRNSAdditional Listing
15th Dec 20217:00 amRNSDirector/PDMR Shareholding
14th Dec 20213:58 pmRNSAnnual Financial Report
9th Dec 20217:00 amRNSLaunch of Responsibility Strategy
1st Dec 202110:47 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSFull Year Results
1st Nov 20213:35 pmRNSTotal Voting Rights
14th Oct 202111:00 amRNSAppointment of Joint Corporate Broker
4th Oct 20217:00 amRNSFull-year performance update & directorate change
1st Oct 20219:21 amRNSTotal Voting Rights
24th Sep 202111:00 amRNSInvestor Webinar
1st Sep 20219:26 amRNSTotal Voting Rights
19th Aug 20219:45 amRNSHolding(s) in Company
16th Aug 20217:00 amRNSAcquisition of Dennis
2nd Aug 20217:00 amRNSTotal Voting Rights and Share Capital
26th Jul 202112:20 pmRNSDirector Declaration
21st Jul 20217:00 amRNSTrading Update
15th Jul 202110:14 amRNSDirector Declaration
1st Jul 20219:30 amRNSBlock listing Interim Review
1st Jul 20219:28 amRNSTotal Voting Rights
10th Jun 20212:59 pmRNSHolding(s) in Company
4th Jun 20217:00 amRNSDirector/PDMR Shareholding
3rd Jun 20215:21 pmRNSDirector/PDMR Shareholding
3rd Jun 20218:35 amRNSHolding(s) in Company
1st Jun 20219:08 amRNSTotal Voting Rights
26th May 20214:21 pmRNSHolding(s) in Company
19th May 20217:00 amRNSHalf Year Results
12th May 20217:00 amRNSAcquisition of Marie-Claire US
11th May 20217:00 amRNSNotice of Results
4th May 20217:00 amRNSTotal Voting Rights
29th Apr 202110:30 amRNSInvestor Webinar
16th Apr 20219:15 amRNSDirector/PDMR Shareholding
1st Apr 20218:51 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.